Literature DB >> 24120331

A cryptic polyene biosynthetic gene cluster in Streptomyces calvus is expressed upon complementation with a functional bldA gene.

Lindsay Kalan1, Arne Gessner, Maulik N Thaker, Nicholas Waglechner, Ximing Zhu, Anjuli Szawiola, Andreas Bechthold, Gerard D Wright, David L Zechel.   

Abstract

Streptomyces calvus is best known as the producer of the fluorinated natural product nucleocidin. This strain of Streptomycetes is also unusual for displaying a "bald" phenotype that is deficient in the formation of aerial mycelium and spores. Genome sequencing of this organism revealed a point mutation in the bldA gene that is predicted to encode a misfolded Leu-tRNA(UUA) molecule. Complementation of S. calvus with a correct copy of bldA restored sporulation and additionally promoted production of a polyeneoic acid amide, 4-Z-annimycin, and a minor amount of the isomer, 4-E-annimycin. Bioassays reveal that these compounds inhibit morphological differentiation in other Actinobacteria. The annimycin gene cluster encoding a type 1 polyketide synthase was identified and verified through disruption studies. This study underscores the importance of the bldA gene in regulating the expression of cryptic biosynthetic genes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24120331     DOI: 10.1016/j.chembiol.2013.09.006

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  22 in total

Review 1.  The Uncommon Enzymology of Cis-Acyltransferase Assembly Lines.

Authors:  Adrian T Keatinge-Clay
Journal:  Chem Rev       Date:  2017-04-10       Impact factor: 60.622

Review 2.  Omics-based natural product discovery and the lexicon of genome mining.

Authors:  Henrique Machado; Robert N Tuttle; Paul R Jensen
Journal:  Curr Opin Microbiol       Date:  2017-11-23       Impact factor: 7.934

3.  Synthetic biology approaches to fluorinated polyketides.

Authors:  Benjamin W Thuronyi; Michelle C Y Chang
Journal:  Acc Chem Res       Date:  2015-02-26       Impact factor: 22.384

4.  Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor.

Authors:  Dylan J McClung; Yongle Du; Dominic J Antonich; Bailey Bonet; Wenjun Zhang; Matthew F Traxler
Journal:  mBio       Date:  2022-05-24       Impact factor: 7.786

5.  Activation and mechanism of a cryptic oviedomycin gene cluster via the disruption of a global regulatory gene, adpA, in Streptomyces ansochromogenes.

Authors:  Jingjing Xu; Jihui Zhang; Jiming Zhuo; Yue Li; Yuqing Tian; Huarong Tan
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

6.  Identification of novel mureidomycin analogues via rational activation of a cryptic gene cluster in Streptomyces roseosporus NRRL 15998.

Authors:  Lingjuan Jiang; Lu Wang; Jihui Zhang; Hao Liu; Bin Hong; Huarong Tan; Guoqing Niu
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

Review 7.  Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenal.

Authors:  Sergio Antoraz; Ramón I Santamaría; Margarita Díaz; David Sanz; Héctor Rodríguez
Journal:  Front Microbiol       Date:  2015-05-13       Impact factor: 5.640

8.  Evolution of cyclizing 5-aminolevulinate synthases in the biosynthesis of actinomycete secondary metabolites: outcomes for genetic screening techniques.

Authors:  Kateřina Petříčková; Alica Chroňáková; Tomáš Zelenka; Tomáš Chrudimský; Stanislav Pospíšil; Miroslav Petříček; Václav Krištůfek
Journal:  Front Microbiol       Date:  2015-08-05       Impact factor: 5.640

9.  Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes.

Authors:  Cheng Lu; Guojian Liao; Jihui Zhang; Huarong Tan
Journal:  Microb Cell Fact       Date:  2015-11-02       Impact factor: 5.328

Review 10.  Emerging strategies and integrated systems microbiology technologies for biodiscovery of marine bioactive compounds.

Authors:  Javier Rocha-Martin; Catriona Harrington; Alan D W Dobson; Fergal O'Gara
Journal:  Mar Drugs       Date:  2014-06-10       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.